Indicated for: obesity; weight management
Route of administration: oral
Substance: sibutramine (centrally acting anorectic)
ATC: A08AA10 (Alimentary tract and metabolism | Antiobesity preparations, excl. diet products | Centrally acting antiobesity products)
Sibutramine is a medication previously used for the treatment of obesity, acting by inhibiting the reuptake of serotonin and norepinephrine, leading to increased satiety and reduced food intake.
The medication has been withdrawn from the market in many countries due to associated risks, such as increased blood pressure and heart rate, which can lead to severe cardiovascular events.
Patients who have used sibutramine should be aware of potential side effects, such as palpitations, hypertension, or insomnia. It is important to inform the doctor of any unusual symptoms.
Common side effects include palpitations, hypertension, and insomnia. In rare cases, severe reactions such as myocardial infarction or stroke may occur. Patients should be informed of these risks before use.